MiR‐200c is also reported to promote BC cell invasion by directly targeting the gene of reversion inducing cysteine‐rich protein with kazal motifs (RECK) by application of oligonucleotides of anti‐miR‐200c to EJ and T24 cells (Cheng et al., 2016). The gene discussed is RECK; the disease is breast cancer.